Prostatis Group’s Putnam Focused Large Cap Value ETF PVAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.31M Sell
114,475
-1,258
-1% -$59.4K 1.36% 14
2025
Q4
$5.27M Buy
115,733
+28,493
+33% +$1.25M 1.26% 17
2025
Q3
$3.73M Buy
+87,240
New +$3.61M 0.93% 28

Other funds holding PVAL

Prostatis Group's PVAL Position: Q1 2026 in Review

Prostatis Group reduced its Putnam Focused Large Cap Value ETF (PVAL) stake by 1.1% in Q1 2026, selling an estimated $59.4K and leaving 114,475 shares worth $5.31M. The position accounts for 1.36% of the portfolio, ranked #14.

Prostatis Group first reported a position in PVAL in Q3 2025 and has held it in 3 quarters since. 314 funds tracked by Wall St. Rank hold PVAL as of Q1 2026.

  • Prostatis Group held 114,475 shares of Putnam Focused Large Cap Value ETF worth $5.31M as of Q1 2026.
  • Prostatis Group sold 1,258 Putnam Focused Large Cap Value ETF shares in Q1 2026, an estimated $59.4K.
  • Putnam Focused Large Cap Value ETF made up 1.36% of Prostatis Group's portfolio in Q1 2026, its #14 holding.
  • Prostatis Group first reported a position in Putnam Focused Large Cap Value ETF in Q3 2025 and has held it in 3 quarters since.
  • 314 funds tracked by Wall St. Rank held Putnam Focused Large Cap Value ETF as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.